The Department of Hepatobiliary Diseases is a key medical discipline in Tianjin and a well-known specialty in China, which has become a diagnosis and treatment and research base of hepatobiliary diseases characterized by the combination of clinical and scientific research, the combination of internal medicine and surgery, and the combination of traditional Chinese medicine and western medicine. The Department of Hepatobiliary Surgery has always kept pace with the international advanced level in the treatment of liver, biliary and pancreatic diseases, and has become an important base for the surgical treatment of primary and metastatic hepatocellular carcinoma, portal hypertension and biliary and pancreatic tumors in Tianjin;
The Department of Hepatobiliary Surgery of the hospital is a key medical discipline of Tianjin and an important base for the surgical treatment of primary and metastatic hepatocellular carcinoma, portal hypertension and biliary and pancreatic tumors in Tianjin. the important base of the hospital. During the thirty years of establishment, the colleagues of Hepatobiliary Surgery have conducted systematic and in-depth researches on various hepato-biliary-pancreatic surgical diseases with unswerving spirit of innovation and love for patients, and have been doing their best to safeguard the health of patients. Under the leadership of Prof. Du Zhi, a famous hepatobiliary surgeon, member of the Council of Chinese Medical Association, member of Chinese Surgical Association, vice chairman of Tianjin Surgical Association, chairman of Tianjin Biomedical Engineering Society, vice chairman of Tianjin Liver Disease Society, and doctoral supervisor, the treatments of liver, gallbladder, and pancreatic diseases have always kept pace with the development of the domestic advanced level, and have been ranked among the national advanced ranks. He has successfully completed more than 2,000 difficult surgeries, such as extreme hepatic resection, central segmental hepatic resection, hepatic resection involving the hepatic vein and vena cava, resection of 12.5 kg rare giant hepatocellular carcinoma, 16 kg giant hepatic hemangioma, resection of cholangiocarcinoma and pancreatic carcinoma, etc., of which the resection of high-grade cholangiocarcinoma is at the leading level of Tianjin City. Prof. Du Zhi firstly proposed and experimentally proved the argument of the existence of molecular margin/boundary of hepatocellular carcinoma at home and abroad. He has established a new hepatic resection method by combining the advanced foreign hepatic resection methods with the Chinese traditional methods, which has improved the cure rate by comprehensive treatment for middle and advanced liver cancer and inoperable patients. Prof. Wang Yijun, a member of Experimental Group of Surgery Branch of Chinese Medical Association, a member of Surgery Branch of Chinese Physicians Association, a vice chairman of Enteral Parenteral Nutrition Branch of Tianjin Medical Association, and a master's degree supervisor, has also become a young subject leader in the field of Hepatobiliary Surgery under the attentive cultivation of Prof. Du Zhi. His comprehensive treatment method for liver cancer has filled the gap in China. In the diagnosis of hepatocellular carcinoma, he has combined with radiology and ultrasonography to perform ultrasonography and DSA examination, and has developed radiofrequency treatment based on chemoembolization of hepatic arteries, local intratumoral injection of anhydrous ethanol, and particle implantation for the treatment of local subcutaneous metastasis of tumors in the early detection of small hepatocellular carcinomas of less than 1CM, which has significantly increased the survival period of patients with hepatocellular carcinomas. In the treatment of pancreatic diseases, countless lives of patients with severe pancreatitis have been saved by adopting the integrated treatment of traditional Chinese and western medicine; for pancreatic malignant tumors, the department actively carries out extended pancreaticoduodenectomy and total pancreatectomy to improve the quality of patients' survival. Difficult surgery has become a highlight of the Department of Hepatobiliary Surgery, and corresponding to this highlight is the exploration of minimally invasive field - for inoperable patients to take radiation intervention arterial chemoembolization combined with ultrasound-guided interventional therapy, so that the tumor shrinkage, and then surgical treatment, which has achieved remarkable efficacy, and its method fills in the domestic gaps. This method fills the gaps in China. In addition, radiofrequency ablation therapy, intratumoral drug injection therapy and high-intensity focused ultrasound therapy for liver cancer have all reached the domestic advanced level. In China, we were the first to carry out ultrasound-guided percutaneous hepatic puncture portal vein catheter drug box system implantation, which provides a way for portal vein treatment with minimally invasive method. Through unremitting efforts, the five-year survival rate after resection of primary liver cancer exceeds 40%. Liver metastatic cancer is an important cause of long-term survival and quality of life for patients with liver disease, and the department endeavors to explore comprehensive treatment modes for liver metastatic cancer, especially liver metastasis from colorectal cancer. It aims to improve the treatment outcome of these patients. The Department of Hepatobiliary Surgery always attaches importance to the development of clinical research and basic research, and always walks in the forefront of academic development. Under the leadership of Prof. Du Zhi, the department has made efforts to study the business and develop new treatment methods, and the overall business has reached a high level, and the resin adsorption device (which has already been industrialized) has won the second prize of the National Scientific and Technological Progress, and the comprehensive treatment of hepatocellular carcinoma has won the third prize of the Scientific and Technological Progress of Tianjin Municipal Science and Technology Progress. The key research project "Comprehensive Treatment of Liver Cancer" undertaken by Tianjin Municipal Science and Technology Commission has achieved milestones, and the researches on blood adsorption treatment of severe pancreatitis, bio-type artificial liver and non-bio-type artificial liver support system have won the Tianjin Science and Technology Progress Award for many times. The research on artificial liver and microcystic adrenal islets have been listed as national 863 research projects, National Natural Science Foundation of China and key research projects of Tianjin Municipality. After years of development, the discipline of liver and gallbladder diseases has been constantly innovating in inheritance and surpassing in innovation, and has become the leader of liver and gallbladder medicine in the city. The Department of Gastroenterology (Liver Diseases) has always insisted on the close integration of scientific research and clinic, and has achieved a series of international advanced and domestic leading results in the basic and clinical research of liver fibrosis.
The Department of Gastroenterology (Liver Disease) of our hospital is an important base for non-surgical treatment of liver disease in Tianjin. Through the efforts of several generations, it has gradually established a high-level medical technology team and a talent echelon with strong comprehensive ability, and it is the Clinical Pharmacology Base of the State Drug Administration, a training base for physicians in Tianjin, a training center for postgraduate students of Tianjin Medical University, and it has undertaken the national "Eleventh Five-Year Plan" and the "National Health Care Plan". It has undertaken the national "Eleventh Five-Year Plan", "973" major research projects, provincial and ministerial-level scientific research projects as well as a number of international and domestic pharmacological and clinical research, and possesses a large number of nationally renowned experts in hepatology such as Prof. Qian Shao-cheng, Prof. Zhang Hui-Zhen, Prof. Kan Zhi-Chao, Prof. Han Tao, etc., with 150 inpatient beds, and an annual capacity of 1,000 inpatient beds. There are 150 inpatient beds, more than 4,000 inpatients and more than 90,000 outpatient visits annually. Under the leadership of Prof. Han Tao, member of Chinese Medical Association Liver Disease Branch, standing committee member of Tianjin Liver Disease Branch, Chinese Medical Association Infectious Disease Branch, vice chairman of Tianjin Infectious Disease Branch, and doctoral supervisor, the department has accumulated a wealth of clinical experience in the prevention and treatment of chronic viral hepatitis, alcoholic liver disease, fatty liver disease, autoimmune liver disease, liver fibrosis, liver cirrhosis and its complications, non-surgical comprehensive treatment of hepatocellular carcinoma, and the rescue of liver failure, etc. The department is constantly innovating. With rich clinical experience and continuous innovation, the Department of Gastroenterology has reached the domestic advanced level in solving the difficult and critical internal diseases, which has alleviated the pains of countless patients, won the praise of patients and their families, and attracted a large number of domestic and foreign patients to come to the Department of Gastroenterology. For more than 30 years, the Department of Gastroenterology (Liver Diseases) has been insisting on business study, tracking and grasping domestic and international developments, scaling the peak of medical science, closely integrating scientific research with clinical practice, and constantly carrying out research and application of new technologies. The department was the first in China to conduct in-depth research on the characteristics of amino acid metabolism in liver disease in 1979, thus promoting the diagnosis and treatment of liver disease. The treatment of liver cirrhosis and hepatic coma with amino acid adjustment and supplementation therapy is at the leading level in China, and the doctrine of branched-chain amino acids has been included in the textbooks of internal medicine. The amino acid preparation "Hepatic Aminosan" developed and researched independently has been clinically proved to be effective in the treatment of decompensated cirrhosis ascites, hypoproteinemia and hepatic coma after more than 20 years of clinical validation, and the molecular pharmacology system for screening anti-hepatic fibrosis drugs has been established, and the mechanism of the rational compounding of anti-hepatic fibrosis traditional Chinese medicine has been explored by using the modern molecular biology technology. It has made international advanced and domestic leading achievements in basic and clinical research on liver fibrosis, and developed "Shu Liver Drinking Pill", a drug for early prevention and treatment of liver cirrhosis, which is applied in clinic and has remarkable therapeutic effect in the treatment of liver fibrosis and early cirrhosis of various etiologies; it has adopted autologous ascites re-infusion technology for the treatment of cirrhosis at an early stage. In China, autologous ascites infusion technology was adopted earlier for the treatment of liver cirrhosis, which can not only rapidly reduce ascites and alleviate the abdominal symptoms of patients, but also is safe, reliable, has little side effects, is economical and practical, and greatly reduces the cost of treatment. Viral hepatitis is currently one of the diseases that have the greatest impact on the health of China's residents. The Department of Gastroenterology (Liver Diseases) applied the molecular diagnostic technology of hepatitis B virus (HBV) at a very early stage, carried out research on the detection of HBV variations, HBVcccDNA, and the detection and clinical application of the patient's immunity indexes, and conducted the whole process of monitoring, early prediction, and early treatment of the HBV variation that appeared in the process of long-term treatment, and adopted the The standardized individualized treatment strategy has improved the therapeutic efficacy of chronic hepatitis B. For other viral hepatitis such as hepatitis C, individualized treatment has been carried out according to its genotype and other characteristics, and better clinical results have been achieved. In the field of liver failure caused by various etiological factors, a series of landmark achievements have been made, including the establishment of early warning and comprehensive intervention system for different periods of liver failure, the comprehensive use of plasma replacement, plasma filtration, plasma perfusion bilirubin adsorption, and other artificial liver model techniques to rescue acute and chronic liver failure and hyperbilirubinemia of various causes, which greatly improved the survival rate of the patients, and reduced the pressure on organ transplantation. The development and clinical application of non-biological artificial liver, such as resin adsorption device, have been carried out first in China. In terms of gastroesophageal variceal rupture and bleeding in liver cirrhosis, we have accumulated rich clinical experience, and now the number of completed cases is the first in China; we have carried out a variety of modes of combined prevention and treatment of rupture and bleeding of esophagogastric fundal varices, including esophagogastric fundal variceal ligation, sclerosing agent injection, tissue binder injection and radiological interventional therapy, etc., and we are the first one to carry out percutaneous hepatic perforation of the gastric coronary vein interventional embolization ( In China, he was the first to carry out percutaneous transluminal gastric coronary vein embolization (PTVE) for the treatment of fundic varices with good results. Over the years, Gastroenterology (Liver Disease) has carried out a series of clinical and research work on liver cancer with sister departments such as Hepatobiliary Surgery, Ultrasound, Radiology, and Institute of Hepatobiliary Diseases, etc., and has carried out selective hepatic artery interventional chemo-embolization, ultrasound-guided radiofrequency ablation, ultrasound/CT-guided intratumoral injection of medicines, bio-immune therapy, and multi-drugs and other comprehensive sequential treatments to the patients who are inoperable and refractory to treatment, greatly prolonging the survival of the patients. Individualized treatment greatly prolongs patients' survival; and a series of researches have been carried out on early diagnosis, early intervention, and control of prevention and recurrence of hepatocellular carcinoma. The Department of Gastroenterology (Liver Disease) has conducted research on autoimmune liver disease, alcoholic liver disease, fatty liver and other fields for a long time in China, and guided clinical treatment. On the other hand, the Department of Gastroenterology (Liver Disease) has also accumulated extensive clinical experience in a number of fields, including gastrointestinal diseases. The Department of Gastroenterology (Liver Disease) has also made remarkable achievements in medical education and research by teaching internal medicine, diagnostics, infectious diseases, and specialized English at the University of Medical Sciences, and by accepting advanced doctors from all over the world for training. Gastroenterology (liver disease) is a focus on academic construction and team spirit of the department, not only adhere to the department every day to read the latest foreign literature, organized weekly business study, the department of difficult cases discussion system, but also actively with other departments to establish close academic cooperation, joint learning, *** with the exploration of difficult cases of treatment, *** with the development of new technology research and application.
The medical staff of the Department of Gastroenterology (Liver Disease) not only strive for technical excellence, but also consider the patient in every way, try to shorten the hospitalization days for the patients, save money, professional, quality service and dedication to serve the patients, and win the trust of the patients, and many patients with liver disease come here for treatment. Nevertheless, they are not satisfied, the medical staff of Gastroenterology (Liver Disease) is continuing to climb on the peak of medicine with full enthusiasm and rigorous scientific spirit, with their practical actions. The Heart Center is the first one in Tianjin to successfully use ECMO technology to rescue dozens of patients with heart failure and respiratory failure caused by various reasons, and the surgeries of various types of valve replacement, congenital heart disease correction and coronary artery bridging are at the leading level in the city. It also carries out interventional therapy for various cardiovascular diseases and emergency PTCA for coronary heart disease.
The Heart Center of Tianjin Third Central Hospital is a brand new cardiovascular disease diagnosis and treatment center which firstly integrates cardiology and cardiac surgery into one in 2007 in China. The Heart Center has 4 chief physicians, 4 deputy chief physicians and 9 attending physicians; among them, 4 are doctors, 5 are masters and 3 are studying for master's degree; 1 is a doctoral supervisor and 2 are master's supervisors; 1 enjoys the governmental special allowance; and undertakes a number of national and municipal scientific research fund projects. She has been awarded the National and Municipal Science and Technology Progress Award for many times.
Medical aspects: in addition to treating common and frequent diseases in cardiovascular department and completing necessary medical work, the department also undertakes the rescue and treatment of cardiovascular critical and difficult diseases; the cardiology group can independently carry out interventional diagnosis and treatment of cardiovascular diseases (including coronary angiography, balloon dilatation and stent implantation), open the green channel for acute myocardial infarction, and save a large number of patients with critical heart disease; it can independently carry out cardiac electrophysiology, which is the best way to treat patients with cardiovascular diseases. The team can independently carry out cardiac electrophysiological examination, radiofrequency ablation treatment of arrhythmias (including supraventricular tachycardia, premature ventricular contractions, atrial fibrillation, atrial flutter, tachypnea and other refractory arrhythmias radiofrequency ablation surgery), and can independently complete the implantation of permanent cardiac pacemakers, cardiac defibrillators, and cardiac synchronization therapy, with a high rate of success in the surgery. The cardiac surgery group carries out total arterialization bypass, which makes the long-term prognosis of surgical bypass surgery better; at the same time, it carries out minimally invasive, small-incision non-stop cardiac bridging surgery, which reduces the medical cost and complications.ECMO (Extracorporeal Membrane Lung Oxygenation) has played a great role in saving critically ill patients at the cardiac center, and the number of cases of ECMO application of the hospital is the first in our city, and it successfully saves the lives of patients with severe myocarditis, acute myocardial infarction (including ECMO-assisted), and other cardiac disorders. (including ECMO-assisted emergency interventions), the former ECMO application in our hospital has reached a leading level in China; through the practice of the past five years, the integrated medical model of cardiology and cardiac surgery has been manifested, and the number of cases of both cardiac interventions and surgical bypass surgeries has increased significantly, which has gained very good clinical and social benefits; at the same time, we were the first to carry out Hybrid (mosaics) surgery in our city. Hybrid (mosaic surgery) to strive for the best medical outcome for patients, and more than ten cases have been completed. Scientific research: In the future, the Cardiac Center will further increase its efforts in scientific research and set up an independent Cardiac Center Laboratory, which will provide theoretical guidance for clinical work while completing daily diagnostic and treatment work. The Department of Emergency Medicine and the Department of Critical Care Medicine have successfully rescued the lives of thousands of patients with cardiac arrest and multi-organ failure of heart, brain, lungs, kidneys and other organs; the comprehensive resuscitation success rate reaches more than 90%.
Hospital Emergency Medicine is one of the five major emergency network hospitals in Tianjin. With strong technical force, it rescues in-hospital and out-of-hospital cardiac arrest patients, and its success rate of cardiopulmonary resuscitation reaches the domestic advanced level, and the comprehensive resuscitation success rate is leading in the city. Rescue all kinds of acute diseases and acute attacks of chronic diseases, including: all kinds of trauma, sudden death, respiratory failure, heart failure, renal failure, acute myocardial infarction, stroke, shock due to various reasons, high fever, coma, vomiting blood, hemoptysis, respiratory distress, acute pain, accidents (electric shock, drowning, self-strangulation, etc.), acute poisoning, multiple organ dysfunction (MODS), etc., and open the "green channel" for critically ill patients. "Green Channel" is opened for critically ill patients to get the whole rescue service in the shortest time, applying dry chemical biochemical test which is immediately available to provide rapid, powerful and comprehensive life support for all kinds of patients with acute and critical illnesses. The Emergency Department is equipped with advanced equipment and technology, including ventilator, automatic gastric lavage machine, two-way wave defibrillator, cardiopulmonary resuscitation machine, cardiac pacing, microinfusion pump, monitor, bedside ultrasound, coronary angiography, stenting, non-invasive hemodynamic monitor, ECMO (artificial cardiopulmonary assist system), and other advanced medical equipments and technologies for the emergency treatment of critically ill patients. Since the completion of the new inpatient building in 2003, the intensive care unit (ICU), as a key discipline of the hospital, has been improving its infrastructure, technical team, research conditions and diagnosis and treatment level, and has reached a leading position in China. There are 20 beds in the ICU, which mainly treats patients with comprehensive diseases, critical illnesses and serious complications after various major surgeries. The department has 20 sets of German Drager and other high-grade ventilators, 20 sets of HP (Philip) monitors, 3 sets of hemofilters, which can routinely complete the invasive pressure, hemodynamics and non-invasive cardiac function (Swan-Ganz catheter, NICO, PiCCO, etc.) monitoring, and can be used to treat the patients in the areas of rescue of sepsis and critical illnesses combined with cardiac, cerebral, pulmonary, renal and other organ failure, compound trauma, clinical nutritional support therapy, etc. The department has also developed a comprehensive treatment program for patients with severe complications after major surgeries and has reached the leading level in China. It has reached the leading level in China in terms of rescue of sepsis and critical illnesses combining heart, brain, lung, kidney and other multi-organ failures, compound trauma, clinical nutritional supportive treatment, etc. The good technical level makes Tianjin ICU Quality Control Center and Tianjin Ventilator Treatment Research Center are located here. ICU was established in 1993. At that time, ICU was still an emerging discipline in the medical field and was mainly responsible for treating patients whose lives were in danger. Under the leadership of Prof. Qin Yingzhi, the leader of the discipline, the ICU has been practicing, learning and summarizing by paying attention to the progress of critical care medicine abroad and studying with dedication and combining with the actual situation of our hospital. Eventually, he led Director Xu Lei and others to gradually understand the basic mode of ICU. And with more than two years of clinical practice and exploration, we have mastered the various mechanical properties and application methods more comprehensively, and developed a more complete set of work system in line with the actual situation of our hospital. 1998, the Municipal Bureau of Health organized an expert to visit the ICU of our hospital and gave a high evaluation, and decided to set up the ICU Quality Control Center of Tianjin City in our hospital. In 2000, the president of German Drager Company visited our hospital and said that the ICU of the hospital had reached the international advanced level through the new mode of clinical research on the application of ventilator in the absence of international technical data for reference, and immediately expressed his willingness to cooperate with the hospital to establish the first domestic center for mechanical ventilation and deconditioning, and invested in expanding the center into a mechanical ventilation training base in the Asia-Pacific region. 2002, May, the "Tianjin Ventilator Center" was established in our hospital.
In May 2002, the "Tianjin Ventilator Therapy Research Center" was established in the ICU of the hospital.
Under the leadership of emergency medicine experts Qin Yingzhi and Xu Lei, the ICU of the hospital has been focusing on the research of respiratory therapy and a number of scientific research topics focusing on mechanical ventilation, concentrating its attention on the research of mechanical ventilation modes, parameters of mechanical ventilation, deconditioning strategies, deconditioning modes, low-assisted ventilation, and autonomous respiratory tests, forming its own characteristics, and taking a place in the field of intensive care medicine in Tianjin and the whole country, and achieving a number of high achievements. It has taken a place in the critical care medical field in Tianjin and the whole country, and has achieved a number of high-level scientific research results. In addition to mechanical ventilation, the department also applies blood purification technology in the treatment of critical illnesses, with ideal results. In 2010 alone, the department successfully saved 571 patients with multiple organ failure. In addition to ordinary blood purification treatment and artificial liver treatment, we are the first to apply albumin adsorption, sodium citrate anticoagulation and other technologies in the city, and the treatment level is among the advanced ones in the country. In addition, our department is the first in the city to carry out auxiliary support for cardiopulmonary resuscitation using ECMO and supportive treatment for patients with severe pneumonia using ECMO, with a success rate of 75%, which is at the international advanced level. At the same time, on the basis of consolidating the original advantages, we aim at the international advanced level, and gradually build the "Center" into a high-level technical personnel echelon integrating talents, equipments, scientific research and clinical practice ability. The concept and technology of Neurology EMG Evoked Potential Examination Center has promoted the development of electrophysiological diagnosis of neuromuscular diseases in Tianjin, which is an important milestone in the development of neurology in Tianjin.
The Department of Neurology of Tianjin Third Central Hospital was established in 1992, looking back at the development of 20 years, both the industry and the community have witnessed the process of its maturity, and now the advanced concepts of its team of neurologists and the high level of medical technology and the hardware facilities of the three centers have made it a real regional center for neurological disorders in Tianjin and a center for scientific research, teaching, postgraduate training and specialized training base for general practitioners. It has also become a base for scientific research, teaching, postgraduate training and specialized training of general practitioners, and has cultivated and transported many talents for the Tianjin area and even the whole country. While winning the praise of the whole society, it has accumulated rich experience in the diagnosis and treatment of neurological diseases and the rescue of critically ill patients. Whether acute stroke patients can receive early and effective treatment can play a crucial role in their healing. With the starting point of grasping this green lifeline of patients, the medical and nursing staff of Department of Neurology has set up an ad hoc channel of intravenous thrombolysis within 3 hours for acute stroke patients since 2001, which minimizes the damage of neurological function and significantly reduces the disability rate and death rate of acute stroke patients. The Department of Neurology carries out nearly 100 cases of intravenous thrombolysis every year, which is in the leading position in the city. In September 2006, under the leadership of Director Zhang Zhecheng, the Department of Neurology, while providing effective treatment for patients, introduced the international advanced KEYPOINT.NET full set of EMG-evoked potential equipment and set up the EMG-evoked potential examination room. This set of the most advanced EMG and video EEG monitoring system plays an important role in the auxiliary diagnosis of central nerve, peripheral nerve, neuromuscular junction and various muscle diseases, and is at the leading level in Tianjin. The establishment of EMG-evoked potential examination room not only creates a precedent of neurophysiological examination in our hospital, but also promotes the rapid development of clinical testing and scientific research in the field of neurophysiology in our hospital and even in the city, and takes the lead to carry out professional training on EMG-evoked potential electrodiagnostics for neurological diseases for neurologists in Tianjin in 2010, which has made a contribution to the further enhancement of neurologists' ability of localization and diagnosis of neurological diseases in the Tianjin area. This has contributed to the further improvement of neurologists' ability to localize and diagnose neurological diseases in Tianjin. The Department of Neurology attaches great importance to scientific research, undertakes several bureau and municipal scientific research projects, and participates in a number of domestic and foreign cooperative research, and has published more than 60 papers. The Department was the first to carry out the "Experimental and Clinical Research on the Effects of Hyperhomocysteinemia and B Vitamins Intervention on Ischemic Stroke", which was awarded the Tianjin Science and Technology Progress Prize in 2010, and was the first to build a new hospital in Tianjin. It was awarded the 2010 Tianjin Science and Technology Progress Award, and has built an internationally advanced research platform for the prevention and treatment of cerebrovascular diseases in Tianjin. The recovery of patients cannot be separated from their own mood and the influence of the surrounding environment. The Department of Neurology creates a warm and comfortable environment for patients, and took the lead in implementing the unaccompanied system for inpatients in the whole hospital in January 2005, and sincerely provides patients and their families with a good medical environment, satisfactory medical and nursing care, and effective treatments, and neurophysiological diagnosis of cerebrovascular and neuromuscular diseases has become the specialized feature of the department. Neurophysiological diagnosis of cerebrovascular disease and neuromuscular disease has become the specialty of the department. The blood purification center is a municipal high-tech base, which adopts continuous renal substitution technology to rescue patients with serious illnesses and improve the success rate.
The Blood Purification Center is a comprehensive department integrating kidney disease treatment and blood purification treatment. From the 1970s, Prof. Song Jichang and Prof. Qian Shaocheng led the medical staff of the Institute of Hepatobiliary Diseases to carry out clinical and basic research on blood purification, and their research results were published in the late 1980s in national journals and Artificial Organ in the United States, and included in relevant journals and magazines abroad. Among them, the research of immunosorbent and blood perfusion technology were in the leading position in China at that time, which were listed as national scientific research projects and won the scientific and technological achievement award of Tianjin for many times, and the products were clinically used by hospitals in more than 20 cities. These researches laid the foundation for the establishment of Blood Purification Center. In 1992, the Blood Purification Center was established and introduced a full set of equipment from Fresenius of Germany, including dialysis machine, water treatment device, central fluid supply system, multi-functional blood purification treatment equipment, etc., and carried out all the projects in the field of blood purification, and also carried out a number of blood purification extension projects, such as the collection and removal of various types of cells in the blood, and collection of immune cells in the treatment of tumors, which made the technical level of the Blood Purification Center in the leading position in the country. The technical level of the center is in the leading position in China. Nearly one hundred hospitals from all over the country, including Hong Kong and Taiwan, have visited and studied in the center, and there are long-term medical research cooperation with many famous hospitals in Beijing and Shanghai. In April 1993, the scientific research project of the Blood Purification Center on comprehensive treatment was listed as a key support project of Tianjin Municipal Science and Technology Commission, and the Center became one of the five high-tech bases of Tianjin Municipal Health Bureau. In 1996, the Blood Purification Center was expanded with an area of 1200m2, which improved the hardware level and environment. Adhering to the high standard, standardized and strict management, the center constantly improves the rules and regulations, and treats every patient with patience, enthusiasm and responsibility, which has gained the trust of the patients. Treating every research with scientific attitude is also recognized by the leaders of the city council and peers. In 2000, the establishment of Nephrology Ward and the development of renal transplantation in the hospital have provided the integrated treatment of blood purification and renal transplantation for the majority of renal patients from early stage renal disease to end-stage renal disease (uremia), realizing a complete nephrology department, and greatly improving the level of renal disease treatment in the hospital and its social influence. The Blood Purification Center has 4 sets of bedside multifunctional blood flow purification equipments, 45 sets of dialysis machines, 2 sets of blood cell separation devices, German water treatment devices and closed central fluid supply system, and other modernized hemodialysis equipments and devices of international advanced level. The center has strong technical force and rich experience in dialysis. The center has strong technical force and rich experience in dialysis. It can carry out many kinds of blood purification treatment techniques, such as conventional hemodialysis, hemodiafiltration, hemofiltration, high efficiency hemodialysis, adjustable sodium dialysis, hemoperfusion, immunosorbent, plasma exchange, and continuous renal replacement therapy (CRRT), etc. The center can rescue critically ill patients in time to carry out CRRT treatment. We insist on the use of high-quality consumables from the perspective of patients' treatment needs. In the treatment, we insist on the implementation of individual dialysis treatment plan to ensure the quality of dialysis and sufficient dialysis time, and give HF or HDF treatment intermittently during the dialysis treatment to ensure the timely elimination of large- and medium-sized molecules of toxins. Due to adequate dialysis and quality assurance, the survival rate and quality of survival of dialysis patients have been greatly improved, and a large number of patients with renal failure, multiple organ failure and refractory acute diseases have been saved, which ensures the success of kidney transplantation. It also applies blood lavage technology to successfully rescue patients with acute drug poisoning, pesticide poisoning and multi-organ failure.
The center applies plasma exchange, plasma replacement, blood filtration and perfusion, immunosorption and other technologies to win time for the Institute of Hepatobiliary Diseases and the treatment of patients with critical liver diseases, and actively carries out the treatment of various cellular components, such as applying the technology of cellular component collection and expansion in blood to the clinic, and the technology of DC-cell stem cell biotherapy to provide new treatment for patients with tumors. The Department of Clinical Nutrition has established and perfected the system of clinical nutrition therapy, which ensures the diet of general hospitalized patients and the treatment and rescue of critically ill patients, and has become a model of the nutrition discipline integrating medical treatment, teaching and scientific research in the field of clinical nutrition in the whole country.
The Department of Nutrition of the hospital is the location of Tianjin Clinical Nutrition Quality Control Center, Tianjin Nutrition Society, and Tianjin Training Base for Nutritionists of China Nutrition Society. The Department of Nutrition continues to broaden the scope of clinical application of nutritional science, forming a specialty in clinical nutritional diagnosis and treatment. It carries out nutritional treatment for patients with clinical critical illness, perioperative period and dozens of nutritional evaluation index tests, establishes and improves the clinical nutritional treatment system, and has become a model of nutritional discipline integrating medical treatment, teaching and scientific research in the field of clinical nutrition in China. The Department of Nutrition undertakes the guidance of nutrition and metabolism support treatment in Tianjin hospitals, and completes the consultation and guidance of nutrition support treatment for critically ill patients with clinical nutrition in dozens of hospitals as well as the preparation of nutrient solution, and its overall work is at the leading level in China. While continuously improving the construction of the discipline, in March 2004, the Department of Nutrition took the lead in the implementation of inpatient "nutritional therapy-type meal system", and with a strictly standardized management system will be scientifically rational nutritional diet and meticulous humane service for patients to create a comfortable and safe medical environment. The Department of Nutrition has nutrition clinic, nutrition metabolism laboratory, food analysis room, intravenous nutrition dispensing room and nutrition therapy room. Anthropometric and body fat measurements, biochemical tests and other means are used to evaluate the nutritional status of patients, and nutritional treatment programs are determined by computer. The inpatient nutrition therapy, metabolic conditioning, nutritional support and scientific assessment and analysis are carried out for the hospitalized patients via intra-gastrointestinal and extra-gastrointestinal nutritional therapy, and reasonable dietary components, nutritional standards and intravenous nutritional therapy programs are formulated for each patient by combining the clinical signs and symptoms. The Nutrition and Metabolism Unit monitors the nutritional status of patients by analyzing their blood and urine. Complete intra- and extra-gastrointestinal nutritional support therapy has solved protein malnutrition or protein-calorie malnutrition in many perioperative, chronically ill, and other critically ill patients, and ensured the treatment and resuscitation of critically ill patients. It has enabled many critically ill patients to achieve the stabilization of the internal environment of the body, restore normal metabolic functioning, enhance the ability to resist disease, and achieve the goal of early recovery. A complete nutritional therapy evaluation system has been established, with more than 20 testing items, reaching the domestic leading level. The first batch of Tianjin health system "integrity department", Tianjin model labor collective, national model labor collective, national "May 1" labor award certificate